SRSF3 is a critical enhancer of alternative splicing, inhibits melanoma growth, and amplifies sensitivity to MAPK-targeted therapies via the p53-MDM4 axis in different human melanoma cell lines and xenograft mouse models derived from patients with melanoma [36, 37]. This evidence concerns the gene MDM4 and melanoma.